{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:10:20Z","timestamp":1777299020717,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1208\/s12248-010-9173-5","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T20:05:38Z","timestamp":1265659538000},"page":"181-187","source":"Crossref","is-referenced-by-count":22,"title":["Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats"],"prefix":"10.1208","volume":"12","author":[{"given":"Eyal","family":"Afergan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meital","family":"Ben David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hila","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nickolay","family":"Koroukhov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Gilhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Rohekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim D.","family":"Danenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gershon","family":"Golomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"issue":"19","key":"9173_CR1","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.ehj.2004.06.011","volume":"25","author":"K Toutouzas","year":"2004","unstructured":"Toutouzas K, Colombo A, Stefanadis C. Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J. 2004;25(19):1679\u201387.","journal-title":"Eur Heart J"},{"issue":"11","key":"9173_CR2","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1592\/phco.24.16.1554.50955","volume":"24","author":"PP Dobesh","year":"2004","unstructured":"Dobesh PP, Stacy ZA, Ansara AJ, Enders JM. Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease. Pharmacotherapy. 2004;24(11):1554\u201377.","journal-title":"Pharmacotherapy"},{"issue":"12","key":"9173_CR3","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.amjcard.2005.02.015","volume":"95","author":"AA Bavry","year":"2005","unstructured":"Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). Am J Cardiol. 2005;95(12):1469\u201372.","journal-title":"Am J Cardiol"},{"issue":"12","key":"9173_CR4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","volume":"119","author":"AA Bavry","year":"2006","unstructured":"Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119(12):1056\u201361.","journal-title":"Am J Med"},{"issue":"1","key":"9173_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193\u2013202.","journal-title":"J Am Coll Cardiol"},{"issue":"9444","key":"9173_CR6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","volume":"364","author":"EP McFadden","year":"2004","unstructured":"McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364(9444):1519\u201321.","journal-title":"Lancet"},{"issue":"3","key":"9173_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijcard.2005.05.029","volume":"109","author":"DW Nilsen","year":"2006","unstructured":"Nilsen DW, Melberg T, Larsen AI, Barvik S, Bonarjee V. Late complications following the deployment of drug-eluting stents. Int J Cardiol. 2006;109(3):398\u2013401.","journal-title":"Int J Cardiol"},{"issue":"17","key":"9173_CR8","doi-asserted-by":"publisher","first-page":"10134","DOI":"10.1073\/pnas.95.17.10134","volume":"95","author":"C Rogers","year":"1998","unstructured":"Rogers C, Edelman ER, Simon DI. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b\/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA. 1998;95(17):10134\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9173_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0021-9150(01)00771-7","volume":"163","author":"A Bayes-Genis","year":"2002","unstructured":"Bayes-Genis A, Campbell JH, Carlson PJ, Holmes Jr DR, Schwartz RS. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair. Atherosclerosis. 2002;163(1):89\u201398.","journal-title":"Atherosclerosis"},{"issue":"6 Suppl","key":"9173_CR10","first-page":"III47","volume":"86","author":"P Libby","year":"1992","unstructured":"Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 1992;86(6 Suppl):III47\u201352.","journal-title":"Circulation"},{"issue":"1","key":"9173_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1191\/1358863x03vm462oa","volume":"8","author":"FG Welt","year":"2003","unstructured":"Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, et al. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med. 2003;8(1):1\u20137.","journal-title":"Vasc Med"},{"key":"9173_CR12","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1166\/jnn.2006.428","volume":"6","author":"E Cohen-Sela","year":"2006","unstructured":"Cohen-Sela E, Dangoor D, Epstein H, Danenberg HD, Golomb G, Gao J. Nanospheres of bisphosphonates attenuate intimal hyperplasia. J Nanosci Nanotech. 2006;6:3226\u201334.","journal-title":"J Nanosci Nanotech"},{"issue":"1","key":"9173_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2006.03.010","volume":"113","author":"E Cohen-Sela","year":"2006","unstructured":"Cohen-Sela E, Rosenzweig O, Gao J, Epstein H, Gati I, Reich R, et al. Alendronate- loaded nanoparticles deplete monocytes and attenuate restenosis. J Controlled Rel. 2006;113(1):23\u201330.","journal-title":"J Controlled Rel"},{"issue":"5","key":"9173_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/00005344-200311000-00014","volume":"42","author":"HD Danenberg","year":"2003","unstructured":"Danenberg HD, Fishbein I, Epstein H, Waltenberger J, Moerman E, Monkkonen J, et al. Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon injury in the rat carotid artery. J Cardiovasc Pharmacol. 2003;42(5):671\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"9173_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/01.CIR.0000023532.98469.48","volume":"106","author":"HD Danenberg","year":"2002","unstructured":"Danenberg HD, Fishbein I, Gao J, Monkkonen J, Reich R, Gati I, et al. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation. 2002;106(5):599\u2013605.","journal-title":"Circulation"},{"issue":"22","key":"9173_CR16","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1161\/01.CIR.0000097002.69209.CD","volume":"108","author":"HD Danenberg","year":"2003","unstructured":"Danenberg HD, Golomb G, Groothuis A, Gao J, Epstein H, Swaminathan RV, et al. Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation. 2003;108(22):2798\u2013804.","journal-title":"Circulation"},{"issue":"9","key":"9173_CR17","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1517\/13543784.10.9.1755","volume":"10","author":"SA Doggrell","year":"2001","unstructured":"Doggrell SA. Statins in the 21st century: end of the simple story? Expert Opin Investig Drugs. 2001;10(9):1755\u201366.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"9173_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0167-5273(02)00195-X","volume":"86","author":"JK Liao","year":"2002","unstructured":"Liao JK. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002;86(1):5\u201318.","journal-title":"Int J Cardiol"},{"issue":"3","key":"9173_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0167-5273(02)00033-5","volume":"83","author":"M Horlitz","year":"2002","unstructured":"Horlitz M, Sigwart U, Niebauer J. Fighting restenosis after coronary angioplasty: contemporary and future treatment options. Int J Cardiol. 2002;83(3):199\u2013205.","journal-title":"Int J Cardiol"},{"issue":"1","key":"9173_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0735-1097(99)00526-4","volume":"35","author":"C Indolfi","year":"2000","unstructured":"Indolfi C, Cioppa A, Stabile E, Di Lorenzo E, Esposito G, Pisani A, et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol. 2000;35(1):214\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"9173_CR21","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1161\/01.CIR.0000018166.84319.55","volume":"105","author":"DH Walter","year":"2002","unstructured":"Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002;105(25):3017\u201324.","journal-title":"Circulation"},{"issue":"2","key":"9173_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2008.08.022","volume":"203","author":"A Blum","year":"2009","unstructured":"Blum A, Shamburek R. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis. 2009;203(2):325\u201330.","journal-title":"Atherosclerosis"},{"issue":"4","key":"9173_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.285.4.430","volume":"285","author":"U Stenestrand","year":"2001","unstructured":"Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285(4):430\u20136.","journal-title":"JAMA"},{"issue":"8","key":"9173_CR24","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S0002-9149(99)00910-8","volume":"85","author":"DH Walter","year":"2000","unstructured":"Walter DH, Schachinger V, Elsner M, Mach S, Auch-Schwelk W, Zeiher AM. Effect of statin therapy on restenosis after coronary stent implantation. Am J Cardiol. 2000;85(8):962\u20138.","journal-title":"Am J Cardiol"},{"issue":"3","key":"9173_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0002-9149(02)02467-0","volume":"90","author":"TJ Bunch","year":"2002","unstructured":"Bunch TJ, Muhlestein JB, Anderson JL, Horne BD, Bair TL, Jackson JD, et al. Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment. Am J Cardiol. 2002;90(3):299\u2013302.","journal-title":"Am J Cardiol"},{"issue":"2","key":"9173_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/PL00002013","volume":"26","author":"M Horlitz","year":"2001","unstructured":"Horlitz M, Sigwart U, Niebauer J. Statins do not prevent restenosis after coronary angioplasty: where to go from here? Herz. 2001;26(2):119\u201328.","journal-title":"Herz"},{"issue":"12","key":"9173_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","volume":"49","author":"G Patti","year":"2007","unstructured":"Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol. 2007;49(12):1272\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"9173_CR28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1056\/NEJM199411173312002","volume":"331","author":"WS Weintraub","year":"1994","unstructured":"Weintraub WS, Boccuzzi SJ, Klein JL, Kosinski AS, King 3rd SB, Ivanhoe R, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. N Engl J Med. 1994;331(20):1331\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"9173_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0002-9149(00)01073-0","volume":"86","author":"HJ Mulder","year":"2000","unstructured":"Mulder HJ, Bal ET, Jukema JW, Zwinderman AH, Schalij MJ, van Boven AJ, et al. Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial). Am J Cardiol. 2000;86(7):742\u20136.","journal-title":"Am J Cardiol"},{"issue":"5","key":"9173_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","volume":"6","author":"J Greenwood","year":"2006","unstructured":"Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nature reviews. 2006;6(5):358\u201370.","journal-title":"Nature reviews"},{"issue":"4","key":"9173_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","volume":"13","author":"SP Luckman","year":"1998","unstructured":"Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ. Nitrogen- containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res. 1998;13(4):581\u20139.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"9173_CR32","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/82219","volume":"6","author":"B Kwak","year":"2000","unstructured":"Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6(12):1399\u2013402.","journal-title":"Nat Med"},{"issue":"12","key":"9173_CR33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","volume":"4","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977\u201387.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"9173_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.trim.2008.02.002","volume":"19","author":"JE Fildes","year":"2008","unstructured":"Fildes JE, Shaw SM, Mitsidou A, Rogacev K, Leonard CT, Williams SG, et al. HMG- CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation. Transpl Immunol. 2008;19(2):152\u20137.","journal-title":"Transpl Immunol"},{"issue":"3","key":"9173_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bbrc.2005.11.099","volume":"339","author":"YC Kim","year":"2006","unstructured":"Kim YC, Song SB, Lee MH, Kang KI, Lee H, Paik SG, et al. Simvastatin induces caspase-independent apoptosis in LPS-activated RAW264.7 macrophage cells. Biochem Biophys Res Commun. 2006;339(3):1007\u201314.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9173_CR36","first-page":"487","volume":"41","author":"A Raz","year":"1981","unstructured":"Raz A, Bucana C, Fogler WE, Poste G, Fidler IJ. Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res. 1981;41(2):487\u201394.","journal-title":"Cancer Res"},{"key":"9173_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0378-5173(94)90433-2","volume":"107","author":"J Monkkonen","year":"1994","unstructured":"Monkkonen J, Valjakka R, Hakasalo M, Urtti A. The effects of liposome surface charge and size on the intracellular delivery of clodronate and gallium in vitro. Int J Pharm. 1994;107:189\u201397.","journal-title":"Int J Pharm"},{"issue":"7","key":"9173_CR38","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1128\/AAC.42.7.1677","volume":"42","author":"EW Etten van","year":"1998","unstructured":"van Etten EW, ten Kate MT, Snijders SV, Bakker-Woudenberg IA. Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system. Antimicrob Agents Chemother. 1998;42(7):1677\u201381.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"9173_CR39","first-page":"45","volume":"32","author":"HM Patel","year":"1998","unstructured":"Patel HM, Moghimi SM. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system\u2014the concept of tissue specificity. Adv Drug Deliv Rev. 1998;32(1\u20132):45\u201360.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"9173_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1011054123304","volume":"18","author":"SM Moghimi","year":"2001","unstructured":"Moghimi SM, Hunter AC. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm Res. 2001;18(1):1\u20138.","journal-title":"Pharm Res"},{"issue":"6","key":"9173_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","volume":"42","author":"SM Moghimi","year":"2003","unstructured":"Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res. 2003;42(6):463\u201378.","journal-title":"Prog Lipid Res"},{"issue":"4","key":"9173_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1208\/s12248-008-9060-5","volume":"10","author":"H Epstein","year":"2008","unstructured":"Epstein H, Gutman D, Cohen-Sela E, Haber E, Elmalak O, Koroukhov N, et al. Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization. AAPS J. 2008;10(4):505\u201315.","journal-title":"AAPS J"},{"issue":"4","key":"9173_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1773-2247(09)50050-0","volume":"19","author":"E Afergan","year":"2009","unstructured":"Afergan E, Epstein H, Koroukhov N, Klein M, Litchi A, Mishani E, et al. Biodistribution and imaging studies of 67 Ga-labeled liposomes in rabbits with a vascular injury. J Drug Deliv Sci Technol. 2009;19(4):263\u20138.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"9173_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2008.08.017","volume":"132","author":"E Afergan","year":"2008","unstructured":"Afergan E, Epstein H, Dahan R, Koroukhov N, Rohekar K, Danenberg HD, et al. Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release. 2008;132(2):84\u201390.","journal-title":"J Control Release"},{"key":"9173_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0076-6879(03)73001-8","volume":"373","author":"N Rooijen van","year":"2003","unstructured":"van Rooijen N, van Kesteren-Hendrikx E. \u201cIn vivo\u201d depletion of macrophages by liposome-mediated suicide. Methods Enzymol. 2003;373:3\u201316.","journal-title":"Methods Enzymol"},{"issue":"3","key":"9173_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jconrel.2006.10.030","volume":"117","author":"H Epstein","year":"2007","unstructured":"Epstein H, Berger V, Levi I, Eisenberg G, Koroukhov N, Gao J, et al. Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. J Controlled Rel. 2007;117(3):322\u201332.","journal-title":"J Controlled Rel"},{"issue":"5","key":"9173_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/cbir.1997.0146","volume":"21","author":"H Hegyesi","year":"1997","unstructured":"Hegyesi H, Csaba G. Time- and concentration-dependence of the growth-promoting activity of insulin and histamine in Tetrahymena. Application of the MTT method for the determination of cell proliferation in a protozoan model. Cell Biol Int. 1997;21(5):289\u201393.","journal-title":"Cell Biol Int"},{"issue":"2","key":"9173_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0021-9150(96)05868-6","volume":"125","author":"G Golomb","year":"1996","unstructured":"Golomb G, Fishbein I, Banai S, Mishaly D, Moscovitz D, Gertz SD, et al. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis. 1996;125(2):171\u201382.","journal-title":"Atherosclerosis"},{"issue":"3","key":"9173_CR49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.ATV.20.3.667","volume":"20","author":"I Fishbein","year":"2000","unstructured":"Fishbein I, Waltenberger J, Banai S, Rabinovich L, Chorny M, Levitzki A, et al. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Arterioscler Thromb Vasc Biol. 2000;20(3):667\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2\u20134","key":"9173_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0009-3084(86)90080-0","volume":"40","author":"AJ Schroit","year":"1986","unstructured":"Schroit AJ, Madsen J, Nayar R. Liposome cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes. Chem Phys Lipids. 1986;40(2\u20134):373\u201393.","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"9173_CR51","first-page":"39","volume":"9","author":"HM Patel","year":"1992","unstructured":"Patel HM. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst. 1992;9(1):39\u201390.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"9173_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0005-2736(93)90270-A","volume":"1153","author":"WV Rodrigueza","year":"1993","unstructured":"Rodrigueza WV, Pritchard PH, Hope MJ. The influence of size and composition on the cholesterol-mobilizing properties of liposomes in vivo. Biochim Biophys Acta. 1993;1153(1):9\u201319.","journal-title":"Biochim Biophys Acta"},{"issue":"3\u20134","key":"9173_CR53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0304-4165(81)90259-2","volume":"677","author":"YJ Kao","year":"1981","unstructured":"Kao YJ, Juliano RL. Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles. Biochim Biophys Acta. 1981;677(3\u20134):453\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"9173_CR54","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1248\/cpb.34.4244","volume":"34","author":"Y Sato","year":"1986","unstructured":"Sato Y, Kiwada H, Kato Y. Effects of dose and vesicle size on the pharmacokinetics of liposomes. Chem Pharm Bull (Tokyo). 1986;34(10):4244\u201352.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"5","key":"9173_CR55","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/oxfordjournals.eurheartj.a060569","volume":"15","author":"H Hanke","year":"1994","unstructured":"Hanke H, Hassenstein S, Ulmer A, Kamenz J, Oberhoff M, Haase KK, et al. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur Heart J. 1994;15(5):691\u20138.","journal-title":"Eur Heart J"},{"issue":"18","key":"9173_CR56","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1161\/hc4301.097195","volume":"104","author":"E Okamoto","year":"2001","unstructured":"Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA, et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 2001;104(18):2228\u201335.","journal-title":"Circulation"},{"issue":"1","key":"9173_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacc.2003.08.026","volume":"43","author":"D Fukuda","year":"2004","unstructured":"Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol. 2004;43(1):18\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9173_CR58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","volume":"90","author":"PR Moreno","year":"1994","unstructured":"Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 1994;90(2):775\u20138.","journal-title":"Circulation"},{"issue":"2","key":"9173_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/humrep\/den375","volume":"24","author":"E Haber","year":"2009","unstructured":"Haber E, Danenberg HD, Koroukhov N, Ron-El R, Golomb G, Schachter M. Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Hum Reprod. 2009;24(2):398\u2013407.","journal-title":"Hum Reprod"},{"issue":"14","key":"9173_CR60","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315\u201323.","journal-title":"N Engl J Med"},{"issue":"3","key":"9173_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer- based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221\u201331.","journal-title":"N Engl J Med"},{"key":"9173_CR62","unstructured":"Web site: \n                    http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00739466\n                    \n                  ."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-010-9173-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-010-9173-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-010-9173-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-010-9173-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:47:47Z","timestamp":1559620067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-010-9173-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9173"],"URL":"https:\/\/doi.org\/10.1208\/s12248-010-9173-5","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]}}}